Propanc Biopharma, Inc. (PPCB) analyst actions
Rating and price-target actions on PPCB in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the PPCB overview →
1 measured PPCB analyst action event.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Propanc Biopharma Initiates $5.0 Million Share Repurchase Program | Press release | -5.25% | -11.50% |
Keep exploring
More PPCB: earnings → · SEC filings → · PPCB overview →
Other Healthcare names and their analyst actions
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Mustang Bio, Inc. (MBIO) | 144 | -0.46% | 41% |
| Patterson Companies, Inc. (PDCO) | 144 | 0.00% | 48% |
| Cara Therapeutics, Inc. (CARA) | 143 | -0.56% | 46% |
| Nutriband Inc. (NTRB) | 143 | 0.00% | 44% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its analyst actions — that is what the link opens.